PTGDS:作为败血性心肌病的特定生物标志物
Linghan Leng1, Chenglin Wang2, Yaxing Deng2
1Department of Intensive Care Unit, Chengdu Fifth People's Hospital (The Second Clinical Medical College, Affiliated Fifth People's Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, Sichuan, People's Republic of China.
研究人员将PTGDS确定为早期败血症检测和预后的新生物标志物. 这一发现为诊断败血性心肌病 (SCM) 和改善患者治疗结果提供了新的目标.
科学领域:
- 生物标志物发现发现
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 败血性心肌病 (SCM) 构成了重大的临床挑战,需要改进早期识别和预后评估策略.
- 目前对SCM的诊断方法缺乏特异性,突出显示了对新生物标志物的需求.
研究的目的:
- 查特定的生物标志物,以检测败血性心肌病 (SCM).
- 确定潜在的研究目标,以早期识别和预后评估SCM.
主要方法:
- 来自败血症患者和健康志愿者的外周血液的RNA测序.
- 不同表达基因和心脏特异性基因的交叉分析.
- 生物信息分析包括PPI,GO和KEGG通路的丰富.
- 用于生物标志物验证的生存分析和ROC曲线分析.
- 单细胞RNA测序用于目标基因的细胞局部化.
主要成果:
- 确定PTGDS作为与败血症预后相关的潜在核心基因.
- PTGDS显示出对败血症具有显著的诊断价值,AUC为0.898.
- 与健康对照组相比,PTGDS表达在败血症患者中发现较低.
- 单细胞RNA测序表明PTGDS在NK细胞和T细胞中的表达.
结论:
- PTGDS是一种新的败血症诊断生物标志物,可能与SCM有关.
- 对于未来的诊断工具开发和败血症的机制研究,PTGDS是一个有希望的目标.
- 这一发现可能有助于更好地临床分层的败血症患者心脏并发症的风险.
更多相关视频
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
09:23Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Myocarditis II: Clinical Features and Diagnostic Tests
